Need professional-grade analysis? Visit stockanalysis.com
$3.51B
98.75
N/A
N/A
TransMedics Group Inc (TMDX) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $115.87, up 6.19% from the previous close.
Over the past year, TMDX has traded between a low of $89.98 and a high of $150.42. The stock has gained 27.0% over this period. It is currently 23.0% below its 52-week high.
TransMedics Group Inc has a market capitalization of $3.51B, with a price-to-earnings ratio of 98.75.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Side-by-side comparison against top Healthcare peers.